Barclays downgrades Tate & Lyle stock to Equalweight on pricing pressure

Barclays has downgraded Tate & Lyle Plc (LON:TATE) to Equalweight from Overweight, slashing its price target to GBP4.30 from GBP6.50. This re-rating follows a recent profit warning from the company and reflects ongoing pricing pressure within its core Food & Beverage Solutions business. Barclays acknowledged its previous upgrade in April 2025 was incorrect, citing emerging threats from GLP-1 penetration and rising consumer concerns about ultra-processed foods as contributing factors to the negative outlook.

Analysis

Barclays has downgraded Tate & Lyle Plc (TATE) to Equalweight from Overweight, accompanied by a significant price target reduction to GBP4.30 from GBP6.50. This revision follows directly from a profit warning issued by Tate & Lyle, which has exacerbated a material decline in its share price since April 2025. The downgrade marks a notable reversal for Barclays, which now acknowledges its April 2025 upgrade was 'clearly wrong', citing the materialization of risks it had previously flagged in October 2023, namely the impact of GLP-1 drugs and consumer aversion to ultra-processed foods. The primary drivers for the current bearish stance are ongoing pricing pressures in the company's core Food & Beverage Solutions (FBS) business, which have negated earlier optimism about margin improvements. The combination of this week's profit warning and earnings cuts announced during the full-year results in May indicates a sustained negative performance trend.

Key Decisions for Investors

• Investors should re-evaluate long positions in Tate & Lyle, as the combination of a profit warning and a significant analyst downgrade signals a deteriorating fundamental outlook.
• Monitor the company's ability to manage pricing power within its core Food & Beverage Solutions division, as this is the central factor driving the current negative sentiment.
• Consider the long-term, secular headwinds from GLP-1 drug penetration and shifting consumer preferences away from ultra-processed foods as material risks to the company's future growth prospects.